A Cigna Foundation grant to Achilles International will help determine whether running holds the key to better mental and physical development for children with autism. The Cigna Foundation today announced its $100,000 World of Difference grant to Achilles International, which has extensive anecdotal evidence showing that walking and running help people on the autism spectrum improve their emotional and physical health.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7252851-cigna-foundation-achilles-international-running-autism-study-grant/
Early findings from a major research initiative of the Crohn’s & Colitis Foundation of America (CCFA) suggest that specific bacteria play a central role in Crohn’s disease and ulcerative colitis (UC), also known as inflammatory bowel diseases (IBD). The evidence raises the possibility of developing new treatments to target the gut microbiome—the “ecosystem” of microbes populating the intestines—linked to the development of IBD.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7204351-crohn-s-colitis-foundation-of-america-gut-bacteria-new-strategies-to-prevent/
Abbott and the United States Department of Defense today announced a collaboration with the intent to develop portable blood tests to help evaluate potential concussions, also called mild traumatic brain injuries (TBIs). As part of a multi–phased approach, the tests would be developed for Abbott’s i–STAT® System, a handheld, diagnostic analyzer that is currently used for other point-of-care testing, including among military service members. Concussions are a significant health concern for military service members.1 With the development of new tests, physicians could use the information to positively impact the care of people with a suspected concussion.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7293951-abbott-u-s-department-of-defense-develop-portable-blood-tests-concussions/
Volvo delivers a unique combination of performance and efficiency with the High Performance Drive-E Powertrain Concept - a triple boost 2-liter 4-cylinder petrol engine with no less than 450 hp.
Following the successful introduction of Volvo’s Drive-E Powertrain range in 2013, Volvo’s powertrain team once again demonstrates its technological leadership in emission-reducing turbo technology.
“When we launched the Drive-E powertrain family, our aim was to deliver the most advanced 4-cylinder engines in the industry based on emissions and fuel consumption relative to performance and drivability. We knew that 320 hp in our petrol configuration was just a starting point. The 450 hp High Performance Drive-E Powertrain Concept, demonstrates this ambition and the versatility of the Drive-E Powertrains,” says Dr. Peter Mertens, Senior Vice President for Research and Development at Volvo Car Group.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/72762550-volvo-reveal-drive-e-450hp-engine/
Even though Colorado State University’s storm-prediction experts anticipate a below-average hurricane season, the second anniversary of Hurricane Sandy serves as a sobering reminder to the families along the Mid-Atlantic coast of the importance for families to be prepared for disasters.
Foundation Expert, Steven Gencorelli, P.E. of Danbro Distributors advises that to elevate safely, securing your foundation with a permanent, deep foundation system is the best option. In an interview on October 15th, Gencorelli provided some advice to individuals still struggling to recover from the devastation of Superstorm Sandy.
Gencorelli helped local communities affected by Hurricane Sandy by providing design assistance for damaged structures and contributed to the development of The Sandy Solution™, which uses helical pile technology.
To view the Multimedia News Release, go http://www.multivu.com/players/English/63264-hubbell-chance-helical-piles-flood-zone-foundation-repair-contractors/
Michelin announced today it will expand the market footprint for its airless skid steer tires with the launch of two new versions of the award-winning MICHELIN® X® TWEEL® SSL airless radial tire: a 12N16.5 X® TWEEL® SSL All Terrain for a wide range of surfaces and a12N16.5 X® TWEEL® SSL Hard Surface for pavement use.
The development of Michelin’s Tweel technology is significant, since skid steer loaders equipped with traditional pneumatic tires, experience at least two or more flat tires per month. Desperate to find a solution to reduce flat-tire downtime, many users resort to using foam-filled, solid tires or other alternatives that result in diminished traction, handling and ride comfort. The 12N16.5 X TWEEL SSL provides the advantages of no air pressure maintenance, easy mounting, damage resistance, increased operator comfort, reduced operator fatigue, improved productivity and longer wear life than pneumatic tires.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7347551-new-michelin-x-tweel-ssl-airless-skid-steer-radial-tires/
Tektronix, Inc., a leading worldwide provider of test, measurement and monitoring instrumentation, has introduced a new class of affordable spectrum analyzers based on a USB architecture with a list price of just $3,490. The new RSA306 sets a new price/performance threshold for spectrum analyzers and features a broad 9 kHz to 6.2 GHz frequency range, 40 MHz real time bandwidth and weighs in at just 1.2 pounds. When used with Tektronix SignalVu-PC software, it offers advanced analysis capabilities for such applications as budget-conscious research and development, mobile radio network installation, interference hunting and university level lab classes.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7074356-tektronix-announces-affordable-full-featured-portable-spectrum-analyzer/
The first International Forum "Future Energy: reducing CO2 emissions" has laid the foundations for the preparation of strategic content for EXPO-2017, the starting point of a broad international dialogue on its subject, "Future Energy".
The event was a platform for the development of research projects on the subject of the exhibition and its sub-topics: reducing greenhouse gas emissions, the introduction of energy-efficient technologies and the provision of universal access to sustainable energy.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7366351-future-energy-reducing-CO2-emissions/
A level IV trauma center in Washington State has installed copper components throughout its facility as another way of reducing hospital-acquired infections and keeping their patients safe.
Pullman Regional Hospital has become an early adopter of antimicrobial copper after studies found that the age-old metal could continuously kill deadly bacteria.
Each year, 2 million people in the United States are diagnosed with a hospital-acquired infection and nearly 100,000 people die. These infections are caused by common bacteria such as E. coli, MRSA, C. diff, CRE and VRE.
“It is a very serious problem,” said Ed Harrich, the director of surgical services for Pullman Regional Hospital. “I think every hospital across the nation is doing everything they can to try to deal with it the best that they can. But there’s bioburden on everything and people aren’t good at hand washing and there’s cross-contamination everywhere you go.”
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7378651-copper-development-association-cda-pullman-regional-hospital-keep-patients-safe-antimicrobial-copper/
Eight out of 10 people will be affected by back pain at some point during their lives, making it the No. 1 cause of disability worldwide and resulting in as much as $200 billion in lost wages and productivity. Many sufferers struggle for years to find relief, but treatment options often only provide short-term relief or, in the case of pain medication, carry serious side effects, including drowsiness, liver damage and potential for addiction. Now, thanks to Hocoma, a leader in the development of robotic and sensor-based medical devices for functional movement therapy, consumers have a new way to improve and sustain low back health in the comfort of their own home.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7370551-hocoma-innovative-medical-device-therapeutic-gaming-technology-valedo-low-back-health/
BMM, Asia’s only Midnight Marathon, was conceived by Rotary Bangalore IT Corridor (RBITC) and the first edition run was held on 19th May 2007. Since then this event is growing from year to year and today people from more than 20 countries are participating in this event and also the number of runners from 2400 in the Year 2007 has increased to 10,000 runners apart from 45 Corporates participating in the event held in 2013, being the seventh edition run. RBITC’s effort in making BMM as a mega event is laudable as it focuses both on bringing about awareness amongst today's youth of the need to be physically fit and mentally strong and also transforming this as a vehicle for raising funds for various charitable activities, aimed at bringing about a difference in the lives of the underprivileged section of the society. To-day BMM has become the largest fund raising platform for RBITC. Some of the major activities undertaken by them are Adoption of Government Schools, Medical Surgeries, Free Eye Surgeries, Holding Blood Donation Camps, Integrated Village Development, Potable Water Project etc.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7398551-bengaluru-midnight-marathon-2014/
Newron Pharmaceuticals S.p.A. (“Newron”), a research and development company focused on novel CNS and pain therapies, and its partner Zambon S.p.A., an international pharmaceutical company strongly committed to the CNS therapeutic area, announced today that the EU Committee for Medicinal Pro-ducts for Human Use (CHMP) recommended that the European Commission approve the use of Xadago™ (safinamide) as add-on to L-dopa alone or in combination with dopamine agonists, entacapone, amantadine, and/or anticholinergics, for the treatment of patients with mid-late stage Parkinson’s disease experiencing motor fluctuations despite being stabilized on ‘Standard of Care’.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7406951-chmp-xadago-parkinsons/
